Emergency Department Triage of Patients With Acute Chest Pain Based on the ESC 0/1-hour Algorithm (PRESC1SE-MI)

NCT ID: NCT05649384

Last Updated: 2025-06-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

64374 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-12-01

Study Completion Date

2026-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The PRESC1SE-MI study compares two algorithms for triage of patients presenting with chest pain and symptoms of heart attack (myocardial infarction) to the emergency department. Both algorithms are recommended by the European Society of Cardiology: the 0/3-hour algorithm and the 0/1-hour algorithm.

Currently, most emergency departments worldwide use the 0/3-hour troponin algorithm. Cardiac troponin (cTn) is a heart-specific biomarker which indicates damage of the heart muscle and which increases after a heart attack. In the 0/3-hour algorithm, the amount of troponin in the bloodstream is measured with a high-sensitivity assay at admission and 3 hours thereafter. Likewise, the 0/1-hour algorithm means that the blood sample in which the troponin is measured is collected at admission and 1 hour later. Since recent clinical studies suggest that the 0/1-hour algorithm is superior to the 0/3-hour algorithm, many hospitals consider switching to the 0/1-hour algorithm.

The aim of this study is to assess how feasible the time-saving 0/1-hour algorithm would be in reality and whether it provides the same accuracy and safety in the diagnosis of myocardial infarction as the current practice the 0/3-hour algorithm.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Chest Pain NSTEMI - Non-ST Segment Elevation MI

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

prospective stepped-wedge cluster randomised controlled trial, sites are randomly assigned to either early initiation or late initiation of the ESC hs-cTnT/I 0/1h-algorithm and compared to the standard of care ESC hs-cTnT/I 0/3h-algorith
Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

0/1-hour algorithm

High-sensitivity cardiac troponin (hs-cTn) blood tests are performed at admission (0 h) and 1 hour later in the emergency department.

Group Type EXPERIMENTAL

European Society of Cardiology hs-cTnT/I 0 h/1 h algorithm

Intervention Type DIAGNOSTIC_TEST

High-sensitivity cardiac troponin (hs-cTn) blood tests are performed at admission (0 h) and 1 hour later in the emergency department.

0/3-hour algorithm

High-sensitivity cardiac troponin (hs-cTn) blood tests are performed at admission (0 h) and 3 hours later in the emergency department.

Group Type ACTIVE_COMPARATOR

European Society of Cardiology hs-cTnT/I 0 h/3 h algorithm

Intervention Type DIAGNOSTIC_TEST

High-sensitivity cardiac troponin (hs-cTn) blood tests are performed at admission (0 h) and 3 hours later in the emergency department.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

European Society of Cardiology hs-cTnT/I 0 h/1 h algorithm

High-sensitivity cardiac troponin (hs-cTn) blood tests are performed at admission (0 h) and 1 hour later in the emergency department.

Intervention Type DIAGNOSTIC_TEST

European Society of Cardiology hs-cTnT/I 0 h/3 h algorithm

High-sensitivity cardiac troponin (hs-cTn) blood tests are performed at admission (0 h) and 3 hours later in the emergency department.

Intervention Type DIAGNOSTIC_TEST

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

0/1-hour algorithm 0/3-hour algorithm

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients aged 18 and above
* Presentation with acute non-traumatic acute chest pain to the emergency department
* Suspicion of acute myocardial infarction

Exclusion Criteria

* Terminal kidney failure requiring dialysis
* Cardiac arrest
* Cardiogenic shock
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Basel, Switzerland

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Christian Müller, MD Prof.

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Basel, Switzerland

Jasper Boeddinghaus, MD

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Basel, Switzerland

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Baylor St. Luke's Medical Center

Houston, Texas, United States

Site Status

St Andrew's War Memorial Hospital Brisbane

Brisbane, , Australia

Site Status

Vienna General Hospital (AKH Wien)

Vienna, , Austria

Site Status

University Central Hospital Helsinki

Helsinki, , Finland

Site Status

Attikon General Hospital Athens

Athens, , Greece

Site Status

Careggi University Hospital Florence

Florence, , Italy

Site Status

Azienda Ospedaliera San Giovanni Addolorata

Roma, , Italy

Site Status

Hospital Città della Salute e della Scienza di Torino

Torino, , Italy

Site Status

Emergency Institute for Cardiovascular Diseases C.C. Iliescu

Bucharest, , Romania

Site Status

Konkuk University Medical Center

Seoul, , South Korea

Site Status

Hospital Clinic Barcelona

Barcelona, , Spain

Site Status

University Hospital October 12 Madrid

Madrid, , Spain

Site Status

University Hospital Ramon y Cajal

Madrid, , Spain

Site Status

Hospital Clínico Universitario Valencia

Valencia, , Spain

Site Status

Kantonsspital Aarau

Aarau, , Switzerland

Site Status

St. Claraspital

Basel, , Switzerland

Site Status

Kantonsspital Luzern

Lucerne, , Switzerland

Site Status

University Hospital Zurich

Zurich, , Switzerland

Site Status

Royal London Hospital

London, , United Kingdom

Site Status

Royal Cornwall Hospitals Treliske

Truro, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Australia Austria Finland Greece Italy Romania South Korea Spain Switzerland United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2019-02269

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.